Crown Bioscience Inc.
SAN DIEGO, June 19, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces that it has been selected by Pierre Fabre Research Institute as one of their partners to advance their immuno-oncology drug discovery pipeline.
CrownBio boasts the world's largest collection of patient-derived xenograft (PDX) models and is a leading provider of humanized solutions for immuno-oncology drug development. Leveraging these exclusive capabilities, CrownBio will engraft PDX models selected by Pierre Fabre into CD34+ humanized mouse models. These customized, humanized models will be used to accelerate Pierre Fabre's innovative immuno-oncology drug discovery pipeline.
"Pierre Fabre recognizes the value of CrownBio's extensive PDX collection and their expertise in implementing innovative humanization strategies," said Nathalie Corvaia, Pierre Fabre's Head of New Biologic Entity Platform and Director of Center of Immunology R&D Pierre Fabre. "We have chosen them as our partner for these reasons and look forward to what we are confident will be a successful alliance."
"We are very pleased that Pierre Fabre has selected us as a trusted partner to advance their cutting-edge immuno-oncology pipeline," said Jean-Pierre Wery, CrownBio's CEO. "Our unique capabilities will enable Pierre Fabre to continue providing new and improved therapies for the treatment of cancer."
About Crown Bioscience Inc.
CrownBio is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, CrownBio enables clients to deliver superior clinical candidates.
Media Enquiries:
Jody Barbeau
Crown Bioscience Inc.
marketing@crownbio.com
WEB:
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
Cellebrite DI Ltd14.3.2024 14:01:14 CET | Press release
Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform
TrueCommerce12.3.2024 13:01:14 CET | Pressemeddelelse
TrueCommerce anerkendes igen som en leder i IDC MarketScape: Worldwide Multi-Enterprise Supply Chain Commerce Network
NetBet4.3.2024 10:41:43 CET | Press release
NetBet Casino in Denmark Now Features IGT PlayDigital Content
NetBet4.3.2024 10:41:43 CET | Pressemeddelelse
NetBet Casino i Danmark indeholder nu spil fra IGT PlayDigital
FUJIFILM Europe GmbH29.2.2024 12:37:58 CET | Press release
Fujifilm Healthcare Europe partners with R Zero to bring next-gen training simulation technology to European endoscopists
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum